Abstract. The human recombination activating gene 1 (RAG1) has previously been mapped to chromosomes 14q and llp. Here we confirm the chromosome 11 assignment by two independent approaches: autoradiographic and fluorescence in situ hybridization to metaphase spreads and analysis of human-hamster somatic cell hybrid DNA by the polymerase chain reaction (PCR) and Southern blotting. Our results unequivocally localize RAG1 to llp13.
Introduction
During lymphocyte development the complete variable domain of immunoglobulins and T-cell receptors is generated by a site-specific multistep process recombining so called variable (V), diversity (D), or joining (J) elements (for reviews see Blackwell and Alt 1988; Davis 1988) . Two adjacent lymphocyte specific genes, RAG1 and RAG2, have been isolated, which are functionally correlated to V(D)J recombinase activity (Oettinger et al. 1990; Schatz et al. 1989) . Recently, RAG1 has been mapped to two different chromosomes, namely 14q21.3-q22.2 (Blanquet et al. 1992 ) and ll(p12-p13) (Oettinger et al. 1992; Ichihara et al. 1992 ). Since we are interested in the molecular characterization of human severe combined immunodeficiency disease (SCID), we isolated the human RAG genes and localized RAG1 by different methods.
Materials and methods
A probe for human RAG1 was prepared by the polymerase chain reaction (PCR) using primers based on published sequences (Schatz et al. 1989) . A pair of primers [RAGI/1, 5"-GACATG-GAAGAAGACATCTTGGAAGG-3" (1827 -1852 and RAG1/2, Correspondence to: K. Schwarz 5"-AGCCCTCAATGCAACCCAGAGG-3" (3309-3288)] amplified a fragment of 1,482 bp. The PCR conditions were as published by Saiki et al. (1988) . The amplification conditions consisted of 35 cycles of denaturation at 94~ for 1 min, annealing at 56~ for 1 min and extension at 72~ for 1.5 min followed by a 10-min 72~ extension step after the last cycle. The identity of the fragment was confirmed by hybridization to the oligonucleotide RAGI/3 (5"AAACTCAATTGCAAAAACCAA-3") under stringent conditions. The 1,482-bp fragment was used to screen a size selected (15 to 20-kb), partially Sau3a digested EMBL 3 human genomic library. One clone (RAG 1 ;3) was used to subclone a 5-kb BamHI-SalI fragment into pT7T3UI8 (Pharmacia). This fragment includes all of the translated part of RAGI as well as part of the first intron. In addition, a 2.5-kb EcoNI-HindIII fragment containi,ng only coding sequences was subcloned. Both subclones were confirmed by sequencing.
In situ hybridization was done as previously published (Perry and Wolff 1974; Kunze et al. 1989) . For non-radioactive in situ hybridization we followed the procedure of Lichter et al. (1990) . Briefly, the 20-kb insert of phage RAG1;3 was nick translated with biotin-ll-dCTP. 100 ng of labeled DNA plus cot-1 DNA (Bethesda Research Laboratories, BRL) and herring sperm DNA (50 and 500 gg/ml final concentration, respectively) were used in 20 gl of hybridization mix per slide. After extensive washing the biotin labeled DNA was detected via fluorescein isothiocyanate (FITC)-avidin. The signal was amplified by binding of biotinylated anti-avidin and a second FITC-avidin detection step. Metaphases were counterstained with 4;6-diamidino-2-phenylindole (DAPI) propidium iodide and photographed on Kodak Ektachrome 400 film.
Results and discussion
Metaphases were prepared according to standard techniques from human lymphocyte cultures. The cultures were labeled with bromodeoxyuridine to allow for fluorochrome-photolysis-Giemsa (FPG) banding analysis (Perry and Wolff 1974) . The procedure for in situ hybridization with 3H-labeled probes was exactly as described previously (Kunze et al. 1989 with a total of 74 grains were evaluated. Thirteen grains (17.6%) accumulated over the region 11 (p12-p13) with a dominant signal over 11 p 13 (Fig. 1) . Interestingly 3 of 74 grains (4%) were observed over 14q22. With non-radioactive in situ hybridization, a symmetric double fluorescence signal is exclusively seen in region 1 lp13 on each of both chromosomes 1 l from more than 20 metaphases analyzed (data not shown).
To position the RAG 1 gene with respect to other markers and to exclude the location at chromosome 14 a panel of human-hamster somatic cell hybrids Gessler et al. 1989; Glaser et al. 1989; Luerssen et al. 1990 ) was analyzed with PCR (primers RAG1/I and RAG1/2 for amplification and oligonucleotide RAG1/3 for hybridization) and Southern blots (detection of a 6-kb human specific EcoRI fragment with the 2.5-kb EcoNIHindlII probe). Hybrid cells (V79Ly 3-2 and V79Ly 2-3) without human chromosome 11, but retaining human chromosome 14, as well as control hamster cell line P3 show no hybridization signal in the PCR analysis ( Fig.  2A, lanes 5-7) , while human buffy coat DNA and hybrid J l -l l , which contains the total short arm of human chro- Fig. 2A,  lanes 1 and 2) . The results of the human-hamster somatic cell hybrid studies (Fig. 2B) place the RAG1 gene on human chromosome 11 between the cell surface marker MIC4 = CD44 and D 11 $9 and further define the centromeric breakpoints of the cell lines J1-9, DAR, N.W. and M.J.
Our analyses thus exclude chromosome 14 and confinn chromosome llp13 as the location of the human RAG1 gene. Furthermore, since human RAG2 is linked to RAG1 on the basis of overlapping genomic clones (K. Schwarz, unpublished data), both genes map in this region. The RAG locus is included in a conserved linkage group that extends in the human karyotype from llpll-llpl3
and is syntenic with a part of the murine chromosome 2 (Davisson et al. 1991) . No known human disease maps to the RAG position on chromosome 11, in particular, there is no observed association between immunodeficiencies and chromosome llp13 abnormalities.
